In this cross-sectional analysis, researchers aimed to characterize the NIH trials affected by grant terminations under the Trump administration. More than 74,000 individuals were enrolled in active ...
(HealthDay News) — The oral small-molecule glucagon-like peptide 1 (GLP-1) receptor agonist orforglipron demonstrates superior weight loss as an adjunct to lifestyle modification versus placebo for ...
Having a longer travel time to their treatment facility improves survival in prostate cancer patients, according to a recent study.
PSMAddition is an international, open-label, prospective, phase 3 randomized controlled trial of 177Lu-PSMA-617 plus ADT and ARPI in PSMA-positive mHSPC.
Authors say widely available foods like tea, coffee, berries, olive oil, nuts, and whole grains may be a practical way to improve long-term cardiovascular disease risk.
No significant differences in mean cost of care or in 30-day readmission for home hospital versus brick-and-mortar hospital care.
(HealthDay News) — Most speakers attending U.S. Food and Drug Administration (FDA) Human Drug Advisory Committee meetings about new drugs or indications support approval, according to a research ...
In this meta-analysis, researchers evaluated the use and/or prolongation of ADT in men with non-metastatic prostate cancer undergoing definitive radiotherapy. For men with prostate cancer treated with ...
“We need organizational strength and stability at the agency,” John Crowley, CEO of the biotechnology trade group BIO, told STAT News. “This constant turmoil is undermining America’s leadership in ...
A study has found a link between exposure to heatwaves and higher ambient temperatures and increased risk of cardiovascular mortality.
(HealthDay News) — Abdominal obesity is associated with more harmful changes to heart structure than body weight alone, according to a study presented at the annual meeting of the Radiological Society ...
(HealthDay News) — For patients with type 2 diabetes, there is an association between glucagon-like peptide-1 receptor agonist (GLP-1 RA) use and chronic cough, according to a study published online ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results